Back to 
UBS Group AG
UBS Group AG
CRDFShowing 8 of 24 quarters
Position history for UBS Group AG's holdings in CARDIFF ONCOLOGY INC
Yes. Ubs holds 638,699 shares of CRDF (Cardiff Oncology), worth $830,309, as of its Q2 2026 13F filing. It increased the position by 238,123 shares (+59.5%) from Q1 2026. Ubs has held CRDF since Q3 2021, across 20 quarterly 13F filings.
Current Value
$830,309
Current Shares
638,699
Total Value Change
+$700,643
Total Shares Change
+590,135
Quarter-by-Quarter History
Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., STATE STREET CORP, Janus Henderson Group Ltd.